Immediate Impact

61 standout
Sub-graph 1 of 25

Citing Papers

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
2024 Standout
2 intermediate papers

Works of K. Kittel being referenced

1801 Neoadjuvant chemotherapy with trastuzumab or lapatinib: Survival analysis of the HER2-positive cohort of the GeparQuinto study (GBG 44)
2015
Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial
2008

Author Peers

Author Last Decade Papers Cites
K. Kittel 174 137 73 12 236
Clay M. Anderson 133 47 71 12 289
Johan M. van Rooijen 138 47 57 16 214
Aurélie Maran-Gonzalez 159 117 82 16 249
Andrea Stefek 140 137 51 14 183
G Moro 110 60 43 15 188
Gabriella Landi 198 115 53 9 282
Eleonora Mioranza 69 59 38 13 122
Massimo Scheibel 178 137 57 14 283
Rosaria Cesaraccio 133 75 50 14 230
Elisabetta Landucci 132 95 39 17 254

All Works

Loading papers...

Rankless by CCL
2026